CD4 and systemic lupus erythematosus: Our study demonstrated that 2DG induced the production of IL-2 from memory CD4+ cells in patients with SLE (Figure 5D), suggesting that 2DG does not only correct the abnormality of Th1 subsets through the control of abnormal cell metabolism but also improve the pathological status of SLE through the induction of IL-2 production.